Peptide-pulsed autologous dendritic cell vaccine (Radboud University)
N/A
Report date: 2022/12/25 13:45:19
Base Information
Drug NamePeptide-pulsed autologous dendritic cell vaccine (Radboud University)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRadboud University Nijmegen
China Registration ClassN/A
Develop Information
Active CompaniesUniversidad Nacional de ColombiaRadboud University Nijmegen
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A